2 Million+
Patients served
200,000+
5-star Reviews
12+
Years in operation
300+
Team members and growing
Book Online
Modern. Clean. Extended hours.
Coverage depends on your exact plan, clinician, location and service. Check participation and expected charges with the clinic and your insurer before booking.
Williamsburg, Brooklyn, NY
Asthma that remains uncontrolled deserves a careful review. Difficult-to-control asthma may reflect inhaler technique, adherence, exposures or another illness. Severe asthma remains uncontrolled despite optimized treatment, or worsens when that treatment is reduced. A specialist assessment helps distinguish these situations before a biologic is selected.
Asthma biologics target specific inflammatory pathways. Allergic asthma may fit Xolair; eosinophilic asthma may fit Nucala, Fasenra, Cinqair or Exdensur. Dupixent has an eosinophilic or oral-steroid-dependent asthma indication. Tezspire’s severe-asthma indication does not require a named eosinophilic phenotype. A laboratory result is one part of choosing treatment, not a ranking of drugs.
Review confirmed asthma, attacks, steroid courses, hospital care and symptoms despite appropriate inhaled treatment. Age limits differ: Nucala, Fasenra and asthma Dupixent start at age 6; Tezspire and Exdensur at 12; Cinqair is for adults; Xolair starts at 6 with qualifying allergic asthma. The clinician matches age, phenotype, prior care and other conditions to the exact label.
Begin with records, lung-function review and optimization of current care. Choose a biologic only after discussing indication, route and goals. Arrange an order, authorization, dispensing and training or administration. Exdensur is a healthcare-provider-administered 100 mg subcutaneous injection every six months. Other asthma biologics have different schedules, and Cinqair is an IV infusion.
Bring spirometry, eosinophil and relevant IgE results, inhalers, allergy history and records of oral steroids, attacks and hospital visits. Include the current action plan and prior biologic response. Tell the clinician about infections, vaccinations, pregnancy plans and reaction history. Ask where spirometry or biomarker testing takes place rather than assuming every Nao clinic performs it.
A biologic does not treat an acute attack. Follow the rescue plan and seek emergency help for severe or rapidly worsening breathing trouble. Continue prescribed controller inhalers; systemic or inhaled steroids should not be stopped abruptly. Review product-specific allergic-reaction and helminth precautions. A long injection interval does not remove the need for day-to-day asthma care.
Track attacks, rescue use, symptoms, sleep, activity and steroid exposure. The treating specialist reassesses response over time and decides whether to continue, switch or adjust other treatment. Results vary and a first dose does not prove success. Confirm missed-dose advice for the actual product; do not self-inject Exdensur or transfer its six-month schedule to another biologic.
Confirm whether the chosen Nao visit covers evaluation, specialist coordination, prescribing or administration. A first appointment does not guarantee a dose. Authorization, pharmacy delivery, storage, an administration order and the clinic’s capacity must be settled first. Ask about visit, drug, administration and testing costs separately and plan the next review before leaving.
Nao Medical Williamsburg: 308 Graham Ave, Brooklyn, NY 11211. Call +1-917-310-3371 to confirm the specific service, clinician and appointment before travelling.
Contact the clinic to confirm this service, the clinician and appointment preparation. General clinic hours may differ from service appointment times.
Nao Medical can coordinate primary care, allergy, pulmonary, testing, and medication-access steps. The first visit does not guarantee biologic eligibility, a specific product, or same-day administration.
Symptoms, prior spirometry, treatment response, and alternative diagnoses are reviewed.
Technique, adherence, triggers, comorbidities, and controller treatment come before biologic selection.
Exacerbations, symptoms, lung function, steroid use, and patient goals guide continuation.
Call 911 for severe breathing difficulty, blue or gray lips, confusion, exhaustion, fainting, or symptoms that do not respond to the prescribed rescue plan. Do not wait for a severe-asthma appointment.
Review Nao Medical's urgent and emergency care guidance. Call 911 for a life-threatening emergency.
Bronx
932 E 174th St, Bronx, NY 10460
Call to arrange a severe-asthma evaluation and discuss biologic treatment. If the plan includes an injection or infusion, confirm the medication, receiving clinic and treatment appointment with the care team.
Queens
37-15 23rd Ave, Astoria, NY 11105
Call to arrange a severe-asthma evaluation and discuss biologic treatment. If the plan includes an injection or infusion, confirm the medication, receiving clinic and treatment appointment with the care team.
Bronx
2063A Bartow Ave, Bronx, NY 10475
Call to arrange a severe-asthma evaluation and discuss biologic treatment. If the plan includes an injection or infusion, confirm the medication, receiving clinic and treatment appointment with the care team.
Brooklyn
341 Eastern Pkwy, Brooklyn, NY 11216
Call to arrange a severe-asthma evaluation and discuss biologic treatment. If the plan includes an injection or infusion, confirm the medication, receiving clinic and treatment appointment with the care team.
Long Island
232 W Old Country Rd, Hicksville, NY 11801
Call to arrange a severe-asthma evaluation and discuss biologic treatment. If the plan includes an injection or infusion, confirm the medication, receiving clinic and treatment appointment with the care team.
Queens
80-10 Northern Blvd, Jackson Heights, NY 11372
Call to arrange a severe-asthma evaluation and discuss biologic treatment. If the plan includes an injection or infusion, confirm the medication, receiving clinic and treatment appointment with the care team.
Queens
90-18 Sutphin Blvd, Jamaica, NY 11435
Call to arrange a severe-asthma evaluation and discuss biologic treatment. If the plan includes an injection or infusion, confirm the medication, receiving clinic and treatment appointment with the care team.
Queens
30-07 36th Ave, Astoria, NY 11106
Call to arrange a severe-asthma evaluation and discuss biologic treatment. If the plan includes an injection or infusion, confirm the medication, receiving clinic and treatment appointment with the care team.
Long Island
135 Mineola Blvd, Mineola, NY 11501
Call to arrange a severe-asthma evaluation and discuss biologic treatment. If the plan includes an injection or infusion, confirm the medication, receiving clinic and treatment appointment with the care team.
Manhattan
259 1st Ave, New York, NY 10003
Call to arrange a severe-asthma evaluation and discuss biologic treatment. If the plan includes an injection or infusion, confirm the medication, receiving clinic and treatment appointment with the care team.
Brooklyn
308 Graham Ave, Brooklyn, NY 11211
Call to arrange a severe-asthma evaluation and discuss biologic treatment. If the plan includes an injection or infusion, confirm the medication, receiving clinic and treatment appointment with the care team.
Product-specific allergic-asthma eligibility, dosing inputs, boxed warning, access, and administration.
Product-specific eosinophilic or steroid-dependent asthma, training, access, and follow-up.
Product-specific severe-asthma access, four-week dosing, administration, and monitoring.
Outside-order coordination, specialty-pharmacy delivery, and confirmed site planning.
Routine care, medication reconciliation, vaccination, and coordination with allergy or pulmonary specialists.
Know when asthma symptoms need urgent care or emergency services instead of a specialty visit.
Confirmation of difficult-to-treat or severe asthma, treatment optimization, phenotype assessment, biologic selection, and response review.
Approved indications, age boundaries, dose inputs, boxed anaphylaxis warning, administration, limitations of use, and patient counseling.
April 2026 CSU indication, asthma indication, administration and training, limitations of use, warnings, and patient counseling.
Severe-asthma indication, age boundary, four-week schedule, administration options, limitations of use, warnings, and common adverse reactions.
Updated August 1, 2026. This information does not replace an individual medical evaluation. A licensed clinician determines diagnosis, medication eligibility, testing, dosing, administration, and follow-up. Contact Nao Medical with a medical-content question or correction.
The Williamsburg clinic is at 308 Graham Ave, Brooklyn, NY 11211. Call the selected clinic to confirm today’s hours, the exact service and the appointment. An address does not prove onsite medication, testing or procedure availability.
A consultation starts with the clinical review and required records. Treatment or a procedure depends on suitability, the actual order, safety checks, staff, supplies and any authorization; booking does not guarantee a dose or procedure that day. Begin with records, lung-function review and optimization of current care. Choose a biologic only after discussing indication, route and goals. Arrange an order, authorization, dispensing and training or administration. Exdensur is a healthcare-provider-administered 100 mg subcutaneous injection every six months. Other asthma biologics have different schedules, and Cinqair is an IV infusion.
Bring spirometry, eosinophil and relevant IgE results, inhalers, allergy history and records of oral steroids, attacks and hospital visits. Include the current action plan and prior biologic response. Tell the clinician about infections, vaccinations, pregnancy plans and reaction history. Ask where spirometry or biomarker testing takes place rather than assuming every Nao clinic performs it.
If the planned medicine is Exdensur, its label uses a healthcare-provider injection every six months. Other asthma biologics have different regimens, including every two, four or eight weeks depending on the product and indication. Ask for the exact medicine and schedule; do not transfer one product’s interval to another.
A biologic does not treat an acute attack. Follow the rescue plan and seek emergency help for severe or rapidly worsening breathing trouble. Continue prescribed controller inhalers; systemic or inhaled steroids should not be stopped abruptly. Review product-specific allergic-reaction and helminth precautions. A long injection interval does not remove the need for day-to-day asthma care. Track attacks, rescue use, symptoms, sleep, activity and steroid exposure. The treating specialist reassesses response over time and decides whether to continue, switch or adjust other treatment. Results vary and a first dose does not prove success. Confirm missed-dose advice for the actual product; do not self-inject Exdensur or transfer its six-month schedule to another biologic.
A biologic does not treat an acute attack. Follow the rescue plan and seek emergency help for severe or rapidly worsening breathing trouble. Continue prescribed controller inhalers; systemic or inhaled steroids should not be stopped abruptly. Review product-specific allergic-reaction and helminth precautions. A long injection interval does not remove the need for day-to-day asthma care.
Exdensur must be administered by a healthcare provider under its US label. Do not self-inject it or transfer its six-month interval to another asthma biologic. Other products have device- and patient-specific training and eligibility rules.
Asthma that remains uncontrolled deserves a careful review. Difficult-to-control asthma may reflect inhaler technique, adherence, exposures or another illness. Severe asthma remains uncontrolled despite optimized treatment, or worsens when that treatment is reduced. A specialist assessment helps distinguish these situations before a biologic is selected. Begin with records, lung-function review and optimization of current care. Choose a biologic only after discussing indication, route and goals. Arrange an order, authorization, dispensing and training or administration. Exdensur is a healthcare-provider-administered 100 mg subcutaneous injection every six months. Other asthma biologics have different schedules, and Cinqair is an IV infusion.
